ACTRN12621001123831已完成未知
A feasibility trial evaluating the safety, acceptability and feasibility of a novel multi-component model of care for youth with Bipolar Disorder I or II.
Orygen0 个研究点目标入组 21 人开始时间: 2021年8月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 15 Years 至 25 Years(—)
- 性别
- All
入选标准
- •1. Age 15 to 25 years
- •2. Diagnosis of BD I or II
- •3. Ability to provide informed consent and/or have a parent or guardian provide consent
- •on their behalf.
- •4. Ability and willingness to nominate an emergency contact person, such as a close
- •family member
排除标准
- •1.Has previously received 6-months of care through a tertiary mental health service or a multi-disciplinary team for bipolar disorder or psychosis.
- •2.Currently requiring tertiary mental health intervention or likely to require tertiary intervention in the next 6 months, due to high level of severity, complexity or risk.
- •3.Experiencing psychosis or manic episode
- •4.Intellectual disability that interferes with the likelihood of the participant receiving benefit from participation as judged by the treating clinician;
- •5.Inability to converse in, or read English. English does not have to be the young person’s primary language; Does not have access to the internet and an internet-enabled device;
- •6.High degree of hostility and impulsivity, as judged by the treating clinician, resulting in the clinician believing that inclusion in the research project may result in harm to the young person or other users (i.e. through interactions in the social network).
- •*Those experiencing a hypomanic episode will be treated, and upon remission, can be admitted to the study.
研究者
相似试验
暂停
1 期
CAPRISA 018 TAF Implant TrialPACTR201809520959443Centre for the AIDS Programme of Research in Sauth Africa550
已完成
不适用
A feasibility study investigating the safety, performance and gastrointestinal transit of the DV3395 device concept in healthy participants.NL-OMON50389ovo Nordisk65
已完成
不适用
The objective of the project will be to assess whether this technology(PPIUCD inserter) iseffective and if its use can be recommended to other women in India and around the world.Post Partum Family Planning methodCTRI/2015/03/005619SAIDUnited States Agency for International Development70
招募中
不适用
A phase I trial of intravenously administered M6229 in critically ill sepsis patientsNL-OMON23213Amsterdam UMC, location AMC16
已完成
不适用
A phase I trial evaluating the safety, tolerability and pharmacokinetics of intravenously administered M6229 in critically ill sepsis patients - *HistoSeps*SepsisNL-OMON51932Academisch Medisch Centrum26
